X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7863) 7863
Publication (715) 715
Book Review (109) 109
Book Chapter (86) 86
Newsletter (19) 19
Book / eBook (17) 17
Conference Proceeding (14) 14
Data Set (5) 5
Magazine Article (4) 4
Dissertation (3) 3
Reference (2) 2
Trade Publication Article (2) 2
Paper (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4878) 4878
index medicus (3297) 3297
female (3153) 3153
neurosciences (3029) 3029
male (2974) 2974
animals (2936) 2936
multiple sclerosis (2730) 2730
clinical neurology (2644) 2644
demyelinating diseases - pathology (2194) 2194
adult (2056) 2056
middle aged (1733) 1733
magnetic resonance imaging (1626) 1626
multiple-sclerosis (1566) 1566
demyelination (1534) 1534
mice (1434) 1434
neurology (1355) 1355
demyelinating diseases (1271) 1271
central-nervous-system (1236) 1236
brain - pathology (1061) 1061
immunology (932) 932
aged (843) 843
brain (840) 840
disease models, animal (832) 832
multiple sclerosis - pathology (823) 823
rats (788) 788
demyelinating diseases - physiopathology (780) 780
demyelinating diseases - diagnosis (734) 734
pathology (709) 709
experimental autoimmune encephalomyelitis (702) 702
diagnosis (677) 677
research (675) 675
lesions (662) 662
adolescent (659) 659
inflammation (649) 649
central nervous system (647) 647
myelin (624) 624
mice, inbred c57bl (617) 617
nervous system (592) 592
remyelination (591) 591
demyelinating disease (582) 582
disease (571) 571
spinal cord - pathology (562) 562
demyelinating diseases - immunology (554) 554
demyelinating diseases - etiology (553) 553
demyelinating diseases - chemically induced (550) 550
research article (548) 548
experimental allergic encephalomyelitis (547) 547
diagnosis, differential (539) 539
medicine (536) 536
analysis (530) 530
mri (523) 523
demyelinating diseases - metabolism (522) 522
child (511) 511
multidisciplinary sciences (488) 488
disease progression (479) 479
young adult (458) 458
autoimmune diseases (452) 452
demyelinating disorders (452) 452
care and treatment (451) 451
science (435) 435
myelin sheath - pathology (409) 409
multiple sclerosis - immunology (405) 405
patients (399) 399
multiple sclerosis - diagnosis (395) 395
demyelinating diseases - complications (393) 393
encephalomyelitis (392) 392
time factors (391) 391
oligodendrocytes (390) 390
immunohistochemistry (389) 389
neuroimaging (373) 373
risk factors (369) 369
health aspects (367) 367
article (356) 356
demyelinating diseases - drug therapy (356) 356
spinal cord (351) 351
medicine & public health (337) 337
multiple sclerosis - physiopathology (337) 337
expression (335) 335
myelin sheath - metabolism (328) 328
cells, cultured (326) 326
spinal-cord (317) 317
axons - pathology (313) 313
myelination (308) 308
clinical immunology (307) 307
magnetic resonance imaging - methods (306) 306
antibodies (303) 303
physiological aspects (302) 302
radiology, nuclear medicine & medical imaging (302) 302
nuclear magnetic resonance--nmr (300) 300
medical research (299) 299
psychiatry (295) 295
development and progression (294) 294
retrospective studies (294) 294
autoimmunity (291) 291
demyelinating diseases - genetics (291) 291
surgery (289) 289
rodents (288) 288
cell biology (281) 281
multiple-sclerosis lesions (281) 281
myelin sheath - physiology (281) 281
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7549) 7549
French (105) 105
Japanese (85) 85
Spanish (80) 80
German (46) 46
Russian (25) 25
Chinese (15) 15
Polish (14) 14
Portuguese (11) 11
Czech (9) 9
Korean (6) 6
Italian (5) 5
Turkish (5) 5
Dutch (2) 2
Serbian (2) 2
Croatian (1) 1
Hungarian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Glia, ISSN 0894-1491, 10/2015, Volume 63, Issue 10, pp. 1714 - 1728
Remyelination is a potent regenerative process in demyelinating diseases, such as multiple sclerosis, the effective therapeutic promotion of which will fill an... 
myelin | oligodendrocyte | remyelination | Oligodendrocyte | Myelin | Remyelination | CONDITIONAL INACTIVATION | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | IGF-I | WHITE-MATTER | MESSENGER-RNA EXPRESSION | SPINAL-CORD | GLIAL-CELLS | NEUROSCIENCES | MULTIPLE-SCLEROSIS | CENTRAL-NERVOUS-SYSTEM | CUPRIZONE-INDUCED DEMYELINATION | Oligodendroglia - metabolism | Receptor, Fibroblast Growth Factor, Type 2 - metabolism | Recovery of Function - drug effects | Demyelinating Diseases - genetics | Receptor, Fibroblast Growth Factor, Type 1 - metabolism | Fibroblast Growth Factors - genetics | Receptor, Fibroblast Growth Factor, Type 1 - genetics | Cell Lineage - drug effects | Cell Differentiation - genetics | Oligodendroglia - drug effects | Basic Helix-Loop-Helix Transcription Factors - metabolism | 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase - genetics | Spinal Cord - pathology | Recovery of Function - physiology | Demyelinating Diseases - chemically induced | Demyelinating Diseases - pathology | Cell Lineage - genetics | Disease Models, Animal | Fibroblast Growth Factors - physiology | Animals, Newborn | Cuprizone - toxicity | Basic Helix-Loop-Helix Transcription Factors - genetics | Mice, Inbred C57BL | Cells, Cultured | Mice, Transgenic | Signal Transduction - genetics | 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase - metabolism | Animals | Chelating Agents - toxicity | Signal Transduction - drug effects | Cell Differentiation - drug effects | Signal Transduction - physiology | Mice | Lysophosphatidylcholines - toxicity | Receptor, Fibroblast Growth Factor, Type 2 - genetics | Fibroblast growth factors | Fibroblasts | Growth factors | Rodents
Journal Article
Journal of Neurology, ISSN 0340-5354, 2008, Volume 255, Issue 1, pp. 1 - 10
Journal Article
CURRENT OPINION IN NEUROLOGY, ISSN 1350-7540, 06/2019, Volume 32, Issue 3, pp. 467 - 474
Purpose of review To review the clinical findings, differential diagnosis, treatment and outcome of pseudotumoral demyelinating lesions including tumefactive... 
MULTIPLE-SCLEROSIS LESIONS | TUMEFACTIVE DEMYELINATION | multiple sclerosis | therapy | pseudotumour | NATALIZUMAB | NEUROSCIENCES | CLINICAL NEUROLOGY | FEATURES | BALOS CONCENTRIC SCLEROSIS | SPECTROSCOPY | atypical | neuroinflammation | FINGOLIMOD | BRAIN | Usage | Diagnosis | Research | Demyelinating diseases | Magnetic resonance imaging | Patient outcomes
Journal Article
Journal Article
Annals of Neurology, ISSN 0364-5134, 09/2012, Volume 72, Issue 3, pp. 419 - 432
Journal Article
Journal of Neurology, Neurosurgery & Psychiatry, ISSN 0022-3050, 05/2017, Volume 88, Issue 5, pp. e1 - e1
ObjectivesTumefactive demyelinating lesions (TDLs) occur spontaneously during the course of MS or as the first manifestation of demyelination and may be... 
Care and treatment | Usage | Demyelinating diseases | Fingolimod | Vaccination
Journal Article
Journal of Neurology, Neurosurgery & Psychiatry, ISSN 0022-3050, 11/2013, Volume 84, Issue 11, pp. 1186 - 1191
Journal Article
Brain, ISSN 0006-8950, 01/2013, Volume 136, Issue 1, pp. 116 - 131
Journal Article